NCT04565847View on ClinicalTrials.gov

The Effects of Salbutamol on Mannitol Induced Cough Responses in Healthy Controls

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2021

Conditions
Cough
Interventions
DRUG

Salbutamol 5mg/mL

Nebulized salbutamol given prior to Mannitol-Induced Cough Challenge

DRUG

Sodium Chloride 0.9% Inhl 3Ml

Nebulized 0.9% saline given prior to Mannitol-Induced Cough Challenge

Trial Locations (2)

L8N 3Z5

McMaster Cardio-Respiratory Research Lab, Hamilton

McMaster University, Hamilton

All Listed Sponsors
lead

McMaster University

OTHER

NCT04565847 - The Effects of Salbutamol on Mannitol Induced Cough Responses in Healthy Controls | Biotech Hunter | Biotech Hunter